Arbutus plans modified Dutch auction tender offer to repurchase up to US$230 million shares at US$5-5.75 each
ABUS•Arbutus plans tender offer for up to US$230 million of shares
Arbutus Biopharma plans a modified Dutch auction tender offer to repurchase up to US$230 million of its common shares.
The company said the price range is set at US$5 to US$5.75 per share, with payment to be made in cash from cash on hand.
The offer is expected to launch around Aug. 24, 2026, and expire around Sept. 29, 2026, unless extended or terminated.
J.P. Morgan Securities has been named dealer-manager for the buyback.
